Johnson & Johnson Agrees to $2B DOJ Settlement
Johnson & Johnson agreed to pay $2.2B and plead guilty to a misdemeanor, ending federal investigations into alleged kickbacks and the marketing of drugs for off-label uses.
EU Regulators to Fine Big Drug Firms
EU antitrust regulators will fine nine drugmakers this month for blocking the entry of cheaper generic medicines to the market.
Amid Medicare Woes, Humana Affirms Weaker Outlook
Humana reaffirmed its fiscal 2013 guidance, acknowledging once again that its full-year earnings could fall below Wall Street expectations.
FDA Bans Generic OxyContin in Bid to Stop Abuse
Regulators banned generic versions of the narcotic OxyContin that could be abused via injection and snorting.
Fmr. Tyco CEO Kozlowski Talks About His Next Chapter
FOXBusiness.com caught up with Former Tyco CEO Dennis Kozlowski who, after 6+ years in prison, is back at work and ready to help fellow inmates get back on their feet.
U.S. Signs up 8.2 Million People so Far for Insurance on HealthCare.gov
The U.S. government signed up 8.2 million people for health insurance through the HealthCare.gov website, including 2.1 million people from the insurers' most sought-after demographic - those aged under 35, the top health official said on Tuesday.
Ways for Seniors to Adapt to No 2016 Cost of Living Adjustment
There will be no cost of living adjustment (COLA) for seniors in their Social Security checks in 2016. Effective since 1975, seniors have received these automatic benefit increases every year with the exception of 2010 and 2011.
Lawmakers Question Effectiveness of Dietary Guidelines
Lawmakers on Wednesday asked federal officials whether Americans should trust the government's dietary guidelines, which inform everything from school lunches to advice from a doctor.
Critics say Senate committee chairman's bill will would weaken rental car and rail safety
Safety advocates say that a Senate transportation bill would allow car rental companies to rent recalled vehicles that haven't been repaired.
The Little-Known Texas Law That Can Save You From Medical Debt
Medical bill collections can come as a huge surprise, particularly if you never received a bill. But consumers are getting some leverage.
Is the FDA Really Ditching 'PHOs' for Good?
Experts weigh in on the FDA’s decision to ditch “partially hydrogenated oils” and how this will really affect consumers.
USDA develops new government label for products free of genetically modified ingredients
The Agriculture Department has developed a new government certification and labeling for foods that are free of genetically modified ingredients.
What's next? Next-generation GMOs could be pink pineapples, purple tomatoes, healthier oils
Cancer-fighting pink pineapples, heart-healthy purple tomatoes and less fatty vegetable oils may someday be on grocery shelves alongside more traditional products.
One-Third of Americans Delaying Health Care Due to Costs
More Americans are insured thanks to the Affordable Care Act, but is affordability an issue? Discover the reasons why so many Americans are delaying health care.
Hackers infiltrate health insurer Anthem, access personal information about customers
Health insurer Anthem says hackers infiltrated its computer network and accessed a swathe of personal information about current and former customers including their incomes and street addresses.
California regulators puzzle over how to know that (driverless) cars of the future are safe
California's Department of Motor Vehicles will miss a year-end deadline to adopt rules governing the self-driving cars of the future.
US and China trade deal could end tariffs on $1 trillion in global sales of high-tech items
A trade deal between the U.S. and China could end tariffs on $1 trillion in global sales of semiconductors, MRI machines, GPS devices, printer ink cartridges, video game consoles and other high-tech items.
After service challenged in court, Lyft says it's starting New York City service
The on-demand ride-sharing app Lyft says it is starting limited service in New York City after reaching agreement with state and city officials to resolve regulatory issues.
Will Congress Scuttle the AbbVie-Shire Merger?
AbbVie's $55B deal to buy Irish drug maker Shire would mark the largest tax inversion ever, as a growing number of U.S. firms eye lower rates overseas.
A new federal law will give patients an unprecedented look at company payments to doctors
When many of us have a medical appointment we're concerned about our finances: how much will we owe out-of-pocket? What's our co-pay? But next time, you may also want to ask your doctors about their financial situation.











